INCYTE CORPORATION Number of Operating Segments
INCYTE CORPORATION (INCY) reported Number of Operating Segments of 1 segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-04-28
- INCYTE CORPORATION number of operating segments for fiscal 2019 was 1.00 item, a 0.00% change from fiscal 2018.
- INCYTE CORPORATION number of operating segments for fiscal 2018 was 1.00 item, a 0.00% change from fiscal 2017.
- INCYTE CORPORATION number of operating segments for fiscal 2017 was 1.00 item, a 0.00% change from fiscal 2016.
- INCYTE CORPORATION number of operating segments for fiscal 2016 was 1.00 item, a 0.00% change from fiscal 2015.
item
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2019-12-31 | 1.00 item 10-K · filed 2020-02-13 |
| 2018-12-31 | 1.00 item 10-K · filed 2019-02-14 |
| 2017-12-31 | 1.00 item 10-K · filed 2018-02-15 |
| 2016-12-31 | 1.00 item 10-K · filed 2017-02-14 |
| 2015-12-31 | 1.00 item 10-K · filed 2016-02-12 |
| 2014-12-31 | 1.00 item 10-K · filed 2015-02-17 |
| 2013-12-31 | 1.00 item 10-K · filed 2014-02-21 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-10 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-10 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-04-30 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-13 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-10-31 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-07 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-08 | |||
| 2021-09-30 | 1.00 segment 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | 1.00 segment 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | 1.00 segment 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-09 | |||
| 2020-09-30 | 1.00 segment 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-05-05 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-10-29 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-07-30 | |||
| 2019-03-31 | 1.00 segment 10-Q · filed 2019-04-30 | |||
| 2018-09-30 | 1.00 segment 10-Q · filed 2018-10-30 | |||
| 2018-06-30 | 1.00 segment 10-Q · filed 2018-07-31 | |||
| 2018-03-31 | 1.00 segment 10-Q · filed 2018-05-01 | |||
| 2017-09-30 | 1.00 segment 10-Q · filed 2017-10-31 | |||
| 2017-06-30 | 1.00 segment 10-Q · filed 2017-08-01 | |||
| 2017-03-31 | 1.00 segment 10-Q · filed 2017-05-04 | |||
| 2016-09-30 | 1.00 segment 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | 1.00 segment 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 1.00 segment 10-Q · filed 2016-05-09 | |||
| 2015-09-30 | 1.00 segment 10-Q · filed 2015-11-03 | |||
| 2015-06-30 | 1.00 segment 10-Q · filed 2015-08-04 | |||
| 2015-03-31 | 1.00 segment 10-Q · filed 2015-04-30 | |||
| 2014-09-30 | 1.00 segment 10-Q · filed 2014-10-30 | |||
| 2014-06-30 | 1.00 segment 10-Q · filed 2014-07-31 | |||
| 2014-03-31 | 1.00 segment 10-Q · filed 2014-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |